Andrew Dudum - 16 Jul 2025 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
16 Jul 2025
Transactions value $
-$2,530,034
Form type
4
Filing time
18 Jul 2025, 16:29:16 UTC
Previous filing
17 Jun 2025
Next filing
23 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dudum Andrew Chief Executive Officer, Director, 10%+ Owner 2269 CHESTNUT STREET, #523, SAN FRANCISCO /s/ Alexandra Cotter Wilkins, Attorney-in-Fact 18 Jul 2025 0001837796

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Sale -$141K -2.79K -2.94% $50.58 92.3K 16 Jul 2025 Direct F1, F2
transaction HIMS Class A Common Stock Sale -$74.1K -1.46K -0.61% $50.82 236K 16 Jul 2025 Held by Trustee of Dudum Family Community Property Trust F1, F3
transaction HIMS Class A Common Stock Sale -$2.31M -46.1K -19.51% $50.24 190K 16 Jul 2025 Held by Trustee of Dudum Family Community Property Trust F1, F4
holding HIMS Class A Common Stock 1.19M 16 Jul 2025 Held by Trustee of AD 2022 GRAT 3 dated 11-28-2022
holding HIMS Class A Common Stock 990K 16 Jul 2025 Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
holding HIMS Class A Common Stock 1.29M 16 Jul 2025 Held by Trustee of AD 2021 GRAT dated 11-1-2021
holding HIMS Class A Common Stock 534K 16 Jul 2025 Held by Trustee of AD 2022 GRAT
holding HIMS Class A Common Stock 187K 16 Jul 2025 Held by Trustee of AD 2025 GRAT 3 dated 5-27-2025
holding HIMS Class A Common Stock 322K 16 Jul 2025 Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021
holding HIMS Class A Common Stock 1.58M 16 Jul 2025 Held by Trustee of AD 2023 GRAT dated 9-5-2023
holding HIMS Class A Common Stock 829K 16 Jul 2025 Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022
holding HIMS Class A Common Stock 2.87M 16 Jul 2025 Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.
F2 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $50.47 - $50.745. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $50.79 - $50.89. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $49.80 - $50.785. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.